The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Guy W. Neff

Division of Digestive Diseases

University of Cincinnati College of Medicine

Cincinnati

OH 45267-0595

USA

[email]@uc.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Digestive Diseases, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0595, USA. 2004 - 2010
  • Department of Medicine, Surgery and Nutrition, University of Miami, Miami, USA. 2004 - 2006
  • University of Cincinnati, Cincinnati, USA. 2004
  • College of Medicine, University of Cincinnati, 231 Albert Sabin Way, MSB Room 6560, USA. 2004

References

  1. Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series. Neff, G., Zacharias, V., Kaiser, T.E., Gaddis, A., Kemmer, N. Liver Transpl. (2010) [Pubmed]
  2. Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin. Neff, G.W., Kemmer, N., Kaiser, T.E., Zacharias, V.C., Alonzo, M., Thomas, M., Buell, J. Dig. Dis. Sci. (2007) [Pubmed]
  3. Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy. Neff, G.W., Kemmer, N., Zacharias, V.C., Kaiser, T., Duncan, C., McHenry, R., Jonas, M., Novick, D., Williamson, C., Hess, K., Thomas, M., Buell, J. Transplant. Proc. (2006) [Pubmed]
  4. Outcomes among patients with end-stage liver disease who are coinfected with HIV and hepatitis C virus. Neff, G.W., Shire, N.J., Rudich, S.M. Clin. Infect. Dis. (2005) [Pubmed]
  5. The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection. Neff, G.W., Shire, N., Ruiz, P., O'Brien, C., Garcia, M., Dela Garza, J., Rudich, S.R., Reddy, K.R. Transplant. Proc. (2005) [Pubmed]
  6. Consumption of dietary supplements in a liver transplant population. Neff, G.W., O'Brien, C., Montalbano, M., DeManno, A., Kahn, S., Safdar, K., Nishida, S., Tzakis, A. Liver Transpl. (2004) [Pubmed]
  7. Sirolimus-associated hepatotoxicity in liver transplantation. Neff, G.W., Ruiz, P., Madariaga, J.R., Nishida, S., Montalbano, M., Meyer, D., Levi, D.M., Tzakis, A.G., O'Brien, C.B. Ann. Pharmacother (2004) [Pubmed]
  8. Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade. Neff, G.W., O'brien, C.B., Nery, J., Shire, N., Montalbano, M., Ruiz, P., Nery, C., Safdar, K., De Medina, M., Tzakis, A.G., Schiff, E.R., Madariaga, J. Liver Transpl. (2004) [Pubmed]
  9. Tenofovir therapy for lamivudine resistance following liver transplantation. Neff, G.W., Nery, J., Lau, D.T., O'Brien, C.B., Duncan, R., Shire, N.J., Ruiz, P., Nery, C., Montalbano, M., Muslu, H., Safdar, K., Schiff, E.R., Tzakis, A.G., Madariaga, J.R. Ann. Pharmacother (2004) [Pubmed]
  10. Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy. Neff, G.W., Montalbano, M., O'Brien, C.B., Nishida, S., Safdar, K., Bejarano, P.A., Khaled, A.S., Ruiz, P., Slapak-Green, G., Lee, M., Nery, J., De Medina, M., Tzakis, A., Schiff, E.R. Transplantation (2004) [Pubmed]
  11. Review article: current status of liver transplantation in HIV-infected patients. Neff, G.W., Sherman, K.E., Eghtesad, B., Fung, J. Aliment. Pharmacol. Ther. (2004) [Pubmed]
  12. Topical testosterone treatment for chronic allograft failure in liver transplant recipients with recurrent hepatitis C virus. Neff, G.W., O'Brien, C.B., Shire, N.J., DeManno, A., Kahn, S., Rideman, E., Safdar, K., Madariaga, J., Rudich, S.R. Transplant. Proc. (2004) [Pubmed]
 
WikiGenes - Universities